Latest / Chicago News Today | 2 Min News | The Daily News Now!
Breakthrough Pill Doubles Survival for Pancreatic Cancer | Chicago News
FDA just approved a game-changing pill for advanced pancreatic cancer—daraxonrasib, now branded Rasonque—targeting the mutated protein found in 90% of cases, which had long been considered “undruggable.” In trials, patients saw survival nearly double with fewer side effects, offering real hope where options were scarce. Though costly at $39,800 per month, the drug’s rapid approval underscores urgency to help patients—and its mechanism could revolutionize treatments for lung cancer and beyond. Not a cure, but a major leap forward in personalized cancer care. Listen in comfort:Get a discount on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.